PATENT CLAIM ANALYSIS

Application Number: 15981915
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["536", "029200"]

Abstract:
The present invention relates to pyrazolotriazolyl nucleoside analogues, oligonucleotide comprising them, and uses thereof. Further the invention relates to a method for reducing gene expression in a cell comprising transfecting the cell with such an oligonucleotide.

Claim (Index 9):
A pharmaceutical composition comprising an RNA oligonucleotide according to  claim 6  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.33333
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14403580', '09528110', '09565699', '14403581', '12192581']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6244891515337219
- 35 USC 102 Novelty (BERT): 0.5671214020317777
- Combined Prediction Score: 0.6187523765835274
- Mean Citation Score: 321.328756
- Max Citation Score: 520.20465
- Similarity Product: 355.87707171291413

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test